Newhouse, United Kingdom

Ronald Palin

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 55(Granted Patents)


Location History:

  • Banton, GB (2003 - 2014)
  • Newhouse, GB (2009 - 2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ronald Palin

Introduction

Ronald Palin is a notable inventor based in Newhouse, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of six patents to his name, he has made strides in developing innovative compounds that address critical medical needs.

Latest Patents

Among his latest patents is the invention of amino-heteroaryl derivatives as HCN blockers. This invention relates to amino-heteroaryl derivatives that possess the general Formula I or a pharmaceutically acceptable salt thereof. These compounds are formulated into pharmaceutical compositions and are intended for the treatment of pain, including neuropathic pain and inflammatory pain. Another significant patent is for 6-mercapto-cyclodextrin derivatives, which serve as reversal agents for drug-induced neuromuscular block. This patent discloses a 6-mercapto-cyclodextrin derivative characterized by a specific general formula, making it highly suitable for reversing drug-induced neuromuscular block.

Career Highlights

Throughout his career, Ronald has worked with prominent companies such as N.V. Organon and Akzo Nobel. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and development.

Collaborations

Ronald has collaborated with notable individuals in his field, including Mingiang Zhang and Simon James Anthony Grove. These partnerships have likely enhanced his research and development efforts.

Conclusion

Ronald Palin's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents not only showcase his creativity but also address significant medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…